May 2021. 
 
   8. Soler--Botija C, et al. Brain. 2002;125(7):1624-1634. 
 
   9. Wang CH, et al. J Child Neurol. 2007;22(8):1027-1049. 
 
  10. Darras BT, Finkel RS. "Natural history of spinal muscular atrophy." In: 
      Sumner CJ, Paushkin S, Ko CP, eds. Spinal Muscular Atrophy: Disease 
      Mechanisms and Therapy, 2nd ed. London, UK: Academic 
      Press/Elsevier;2017:399--421.

# # #

Novartis Media Relations

E-mail: media.relations@novartis.com 


 
Anja von Treskow                      Farah Bulsara Speer 
 Novartis External Communications      SVP, Corporate Communications, 
 +41 79 392 8697 (mobile)              Novartis Gene Therapies 
 anja.von_treskow@novartis.com         +1 312 543 2881 (mobile) 
 Julie Masow                           farah.speer@novartis.com 
 Novartis US External Communications 
 +1 862 579 8456 
 julie.masow@novartis.com

Novartis Investor Relations

Central investor relations line: +41 61 324 7944

E-mail: investor.relations@novartis.com 


 
Central                                 North America 
Samir Shah             +41 61 324 7944  Sloan Simpson  +1 862 778 5052 
Thomas Hungerbuehler   +41 61 324 8425 
Isabella Zinck         +41 61 324 7188

# # #

(END) Dow Jones Newswires

June 18, 2021 12:30 ET (16:30 GMT)